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Abstract
An initial linkage analysis of the alcoholism phenotype as defined by DSM-III-R criteria and
alcoholism defined by DSM-IV criteria showed many, sometimes striking, inconsistencies. These
inconsistencies are greatly reduced by making the definition of alcoholism more specific. We
defined new phenotypes combining the alcoholism definitions and the latent variables, defining an
individual as affected if that individual is alcoholic under one of the definitions (either DSM-III-R or
DSM-IV), and indicated having a symptom defined by one of the latent variables. This was done for
each of the two alcoholism definitions and five latent variables, selected from a canonical
discriminant analyses indicating they formed significant groupings using the electrophysiological
variables. We found that linkage analyses utilizing these latent variables were much more robust
and consistent than the linkage results based on DSM-III-R or DSM-IV criteria for definition of
alcoholism. We also performed linkage analyses on two first prinicipal components derived
phenotypes, one derived from the electrophysiolocical variables, and the other derived from the
latent variables. A region on chromosome 2 at 250 cM was found to be linked to both of these
derived phenotypes. Further examination of the SNPs in this region identified several haplotypes
strongly associated with these derived phenotypes.
Background
An often challenging and sometimes underappreciated
facet of genetic epidemiology is the process of choosing an
appropriate definition of the trait of interest. Consider for
example Alzheimer's disease. While advanced age is the
main risk factor for this disease, and it most often strikes
after age 65, there are people that develop this disease
before the age of 50. Pathologically, the disease appears
the same regardless of the age of onset: microscopic exam-
ination of brain tissue from patients that are struck with
this disease at any age reveal the presence of both amyloid
plaques and neurofibrillary tangles. However, it is now
recognized that the patients with the very early ages of
onset have a mutation in one of three genes (APP, PS1,
PS2), and patients that develop Alzheimer's disease at a
later age lack these mutations [1,2]. Early-onset Alzhe-
imer's disease is inherited as a Mendelian dominant trait,
while the more common form of the disease is a complex
trait with a significant environmental component. Thus,
any genetic analysis of Alzheimer's disease that did not
include age of onset as a component of the disease defini-
tion would suffer greatly from the shortcoming known to
epidemiologists as misclassification bias. A linkage or
association analysis of Alzheimer's disease using only the
pathological definition of the disease and ignoring the age
of onset would be mixing cases with two distinct genetic
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etiologies. This could result in a severe loss of power to
detect a disease predisposing variant of a gene.
This problem is even more complicated with a behavio-
rally defined phenotype such as alcoholism, as there is no
completely objective laboratory test for the phenotype. In
this analysis, we explore the problem of phenotype defini-
tion with the Collaborative Study on the Genetics of Alco-
holism (COGA) dataset, and look at alternate definitions
of the phenotype. Of particular interest is the problem of
lack of consistency in results due to a change in the defi-
nition of alcoholism from DSM-III-R to DSM-IV criteria
[3].
Methods
We performed model-free linkage analyses using the pro-
gram SIBPAL, part of the SAGE analysis package [4]. Initial
analyses used only microsatellite data. This was later fol-
lowed up with a combination of microsatellite and
Affymetrix single-nucleotide polymorphism (SNP) data
using the microsatellite map and the latest SNP map sup-
plied with the data. Data preparation and analyses that
did not require accounting for family structure were per-
formed with SAS version 9.0 [5]. This included use of the
procedures CANDISC to perform canonical discriminant
analysis based on canonical correlation, and PRINCOMP
to perform principal components analysis. These tech-
niques were used only as convenient data summary and
reduction techniques. Requirements that would make
either canonical discriminant analysis or principal com-
ponent analysis statistically valid (i.e., normality, inde-
pendence) were not met; however, because we were not
directly forming inferences from these results, this is not a
major consideration in the current work. SIBPAL performs
linkage analysis based on the Haseman-Elston technique
[6,7]. Family-based tests of association were performed
with the program FBAT [8-10]. Haplotype block structure
of the SNPs was explored with the program HAPLOVIEW
[11] using the algorithm defined by Gabriel et al. [12].
Results
Studies to increase concordance of linkage signals
Two sets of linkage analyses were performed using two
different phenotypes: the phenotype of alcoholism
defined by each of the two criteria: DSM-IIIR and DSM-IV.
These were coded as dichotomous variables, and denoted
respectively as Alc1 and Alc2. The following covariates
were used in all linkage analyses: dichotomous indicator
of habitual smoking; dichotomous indicator of whether
an individual was Black (derived from ethnicity); dichot-
omous indicator of whether an individual was White
(derived from ethnicity); age at interview; square of age at
interview; cube of age at interview. The results of the ini-
tial linkage analyses are shown in Figure 1. The differences
in linkage signal when using the two different definitions
of alcoholism (Alc1 for DSM-III-R, Alc2 for DSM-IV) are
seen throughout the genome.
We then made the assumption that the latent variables
and electroencephalogram (EEG) variables are pheno-
types that could be used to identify more homogeneous
alcoholism phenotypes. We performed a canonical discri-
minant analysis using each of the latent variables as a
potential grouping variable for the EEG variables.
Although the p-values are not valid due to the non-inde-
pendence of family members, they gave us an approxima-
tion of the relationships between the latent variables and
the EEG variables. We found that latent variables 1 (per-
sistent desire to stop drinking), 2 (morning drinking), 7
(gave up activities to drink), 9 (withdrawal symptoms),
and 11 (emotional psychological problems from drink-
ing) showed evidence of significant grouping with the
EEG variables. Motivated by these observations, we
defined ten derived phenotypes named Ai_j for i = 1, 2
and j = 1, 2, 7, 9, or 11 as defined above; an individual was
affected with derived phenotype Ai_j if they were defined
as alcoholic under definition 'i' and also had the symptom
defined by latent variable 'j'. Correlations between these
phenotypes were all higher than those between the origi-
nal Alc1 and Alc2 variables (data not shown), and as
shown in Figure 2, these phenotypes are much more con-
sistent in their linkage signals than those previously
observed using diagnoses based on DSM-IIIR and DSM-IV
criteria alone.
To investigate linkage for phenotypes derived from the
EEG variables and the latent variables, we formed several
phenotypes using principal components analysis to sum-
marize collections of variables. We used the first principal
Initial linkage analysis on chromosome 2 Figure 1
Initial linkage analysis on chromosome 2. SIBPAL link-
age analysis on chromosome 2 using only STR data. Out-
come variables are alcoholism by DSM-III-R criteria (Alc1 – 
solid line) and alcoholism by DSM-IV criteria (Alc2 – dotted 
line). Y-axis is the value of the Haseman-Elston regression 
coefficient. Significant values are indicated with circles.
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component derived from all 13 EEG variables, and also
the first principal component derived from alcoholism
and latent variables. The comparison of the linkage results
for these two outcomes is given in Figure 3. There is one
region in the neighborhood of 250 cM on chromosome 2
that shows significant linkage with both of the principal
component derived phenotypes. While a peak around 100
cM is present in both, it is only significant with the latent
variable prinicipal component phenotype.
SNP fine mapping on chromosome 2q
We chose to follow up on these chromosome 2 results,
especially in the area around 250 cM, with further analy-
ses using the Affymetrix SNP data. We examined the evi-
dence for linkage using only the SNP data for all of
chromosome 2. The linkage results for the EEG principal
component outcome is shown in Figure 4 and that for
latent variable principal component is shown in Figure 5.
These results confirm the short tandem repeat (STR) evi-
dence for linkage to the 250-cM region just before the q-
terminus for these outcome variables, though the peak
signal shifted centromerically to ~220 cM.
To attempt to narrow the linkage peaks on 2q, we com-
bined the STR and SNP markers, utilizing a combined
map based on the map data sent along with the marker
file, which produced the linkage results for our alcohol
and latent variable and EEG principal component out-
comes shown in Figure 6.
We used the program FBAT to examine evidence for asso-
ciation between SNP genotypes and each of the outcome
variables of interest. There were a total of ten phenotypes
of type Ai_j, and the two principal component derived
phenotypes mentioned above (EEG, and alcoholism/
latent). Each association can be tested using either a dom-
inant model for mode of inheritance (i.e., one allele or
haplotype dominant over all other alleles or haplotypes),
or an additive model (i.e., risk increasing additively with
each addition copy of the allele or haplotype). Thus, for a
given SNP, up to a total of 24 association tests can be sig-
Linkage analysis of derived phenotypes Figure 2
Linkage analysis of derived phenotypes. SIBPAL linkage analysis on chromosome 2 using only STR data. Outcome varia-
bles are phenotypes derived from Alc1 (DSM-III-R criterion of alcoholism) or Alc2 (DSM-IV criterion of alcoholism) and latent 
variable 1, 2, 7, 9, or 11. Results from phenotypes derived from Alc1 are graphed as solid lines; those derived from Alc2 are 
graphed as dotted lines. Y-axis is the value of the Haseman-Elston regression coefficient. Significant values are indicated with 
circles. The graph from Figure 1 is also included for comparison.
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nificant. Figure 7 shows the number of significant associ-
ations that were found for each SNP in this region by SNP
position in centimorgans.
We followed up on these results by examining the associ-
ations between these outcome variables and haplotypes
formed from SNPs in this region using the HBAT function
in the program FBAT. We chose haplotypes based on three
criteria: 1) if there were consecutive SNPs that all showed
a large number of significant results in Figure 6; 2) if there
were consecutive SNPs with identical positions according
to the Affymetrix map; and 3) if there were consecutive
SNPs determined to be in the same haplotype block by
HAPLOVIEW. Using the three criteria, we find the follow-
ing haplotypes to be significantly associated with most of
our phenotypes of interest: using the first we find haplo-
type tsc0548180|tsc0512074 at positions 209.412–
210.28; using the second criteria, we find haplotypes
tsc0052569|tsc0530060 at 225.8190 and
tsc0977679|tsc0977680 at 226.7420; and finally using
the third criteria, we find tsc1282391|tsc0539848 at
206.707–206.751, and tsc0675766|tsc0040071 at
228.372–228.455. Only the first of these
(tsc0548180|tsc0512074) was significantly associated
with the first EEG principal component. However, there is
a 5-SNP haplotype
(tsc0045051|tsc0620679|tsc0620681|tsc1612284|tsc052
4593; based on the third criterion) at 234.047–235.395
that is significantly associated with this first EEG principal
component.
Discussion
We have identified several alternative phenotypes defined
by use of latent and/or EEG variables that provide consist-
ent linkage signals on 2q using STR markers. We con-
firmed this signal on 2q using the Affymetrix SNP data.
We then combined the SNP and STR data and show that
the combined information narrows the region and
increases the evidence for a candidate region with suscep-
tibility genes for Alcoholism or related traits.
Previous linkage analysis on comorbidity of alcohol
dependence and habitual smoking revealed a modest
SNP Linkage analysis of alcoholism and latent variable princi- pal component phenotype Figure 5
SNP Linkage analysis of alcoholism and latent varia-
ble principal component phenotype. SIBPAL linkage 
analysis on chromosome 2 using only SNP data. Outcome 
variable is the first principal component calculated from both 
alcoholism definitions and all latent variables. Y-axis is the 
value of the Haseman-Elston regression coefficient. Signifi-
cant values are indicated with circles.
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Linkage analysis of principal component phenotypes Figure 3
Linkage analysis of principal component phenotypes. 
SIBPAL linkage analysis on chromosome 2 using only STR 
data. Outcome variables are the first principal components 
calculated from, respectively: all 13 EEG (electrophysiologi-
cal) variables; both alcoholism definitions and all latent varia-
bles. Y-axis is the value of the Haseman-Elston regression 
coefficient. Significant values are indicated with circles.
0 50 100 150 200 250
0
.
0
0
.
5
1
.
0
1
.
5
EEG, Chromosome 2
●
●
●
●
●
●
●
●
● ●
●
●
●
0 50 100 150 200 250
−
0
.
5
0
.
0
0
.
5
1
.
0
1
.
5
Alc and Lat, Chromosome 2
●
● ●
●
● ●
● ●
● ●
●
● ●
● ●
● ●
●
●
● ●
SNP Linkage analysis of EEG principal component phenotype Figure 4
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phenotype. SIBPAL linkage analysis on chromosome 2 using 
only SNP data. Outcome variable is the first principal compo-
nent calculated from all 13 EEG (electrophysiological) varia-
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peak on chromosome 2 around 90 cM, while evidence for
linkage to our region of interest was weak and inconsist-
ent in that study [13]. Linkage to activity of platelet
monoamine oxidase utilizing the COGA dataset was
found on chromosome 2 [14]. The region of chromosome
2 in which we found evidence of linkage is consistent with
some previous results found for eletrophysiological varia-
bles [15] utilizing this same dataset.
Investigating multi-SNP haplotype associations, we find
that there are three SNP haplotypes showing consistent
and significant associations at positions ~206, 210, and
228 cM on chromosome 2q. However, the principal com-
ponent derived phenotypes were not found to show sig-
nificant haplotype associations as those found with the
latent variables. However there is a 5-SNP haplotype at
234.0–234.5 that shows significant association with the
EEG principal component. We have analyzed multiple
phenotypes and multiple SNP haplotypes for these associ-
ation-based analyses, a total of 24 separate analyses, and
have reported here the uncorrected p-values. Application
of the conservative Bonferroni correction can be easily
applied to these p-values, though this study is hypothesis
generating rather than hypothesis testing, so we felt this
unnecessary. Our results mirror the linkage signal previ-
ously found utilizing EEG phenotypes reported by Porjesz
et al. [15].
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Combined STR and SNP linkage analysis of derived phenotypes and EEG principal component phenotype Figure 6
Combined STR and SNP linkage analysis of derived phenotypes and EEG principal component phenotype. SIB-
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ted lines. Outcome variable for the last graph is the first principal component calculated from all 13 EEG (electrophysiological) 
variables. Y-axis is the value of the Haseman-Elston regression coefficient. Significant values are indicated with circles.
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Number of significant SNP associations by position on chro- mosome 2 Figure 7
Number of significant SNP associations by position 
on chromosome 2. Of the total 24 possible associations 
that could be tested for a SNP (see text), the number that 
were found to be significant (p < 0.05) by the FBAT test.
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